These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 32000382

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
    Turakhia SK, Murugesan G, Cotta CV, Theil KS.
    J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
    [Abstract] [Full Text] [Related]

  • 4. Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation.
    Xia D, Hsi ED, Dal Cin P, Hasserjian RP.
    Am J Hematol; 2019 Apr; 94(4):504-505. PubMed ID: 30105753
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene.
    Diamond JM, de Almeida AM, Belo HJ, da Costa MP, Cabeçadas JM, Abecasis MM.
    Ann Hematol; 2016 Dec; 95(12):2101-2104. PubMed ID: 27699446
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.
    Yoon SY, Jeong SY, Kim C, Lee MY, Kim J, Kim KH, Lee N, Won JH.
    Cancer Res Treat; 2020 Jul; 52(3):987-991. PubMed ID: 32019282
    [Abstract] [Full Text] [Related]

  • 14. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia.
    Rostami G, Hamid M, Jalaeikhoo H.
    Gene; 2017 Sep 05; 627():202-206. PubMed ID: 28627443
    [Abstract] [Full Text] [Related]

  • 15. The effectiveness of interferon-α combined with imatinib in patient with chronic myeloid leukemia harboring T315I BCR-ABL1 mutation.
    Zhang H, Liang Z, Hu Y, Wang X, Wang B, Huang H.
    Leuk Lymphoma; 2018 Dec 05; 59(12):3018-3019. PubMed ID: 29616854
    [No Abstract] [Full Text] [Related]

  • 16. Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib.
    Rostami G, Hamid M, Yaran M, Khani M, Karimipoor M.
    J Hum Genet; 2015 May 05; 60(5):253-8. PubMed ID: 25740611
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India.
    Sazawal S, Chikkara S, Singh K, Chaubey R, Chandra D, Mishra P, Mahapatra M, Seth T, Saxena R.
    Ann Diagn Pathol; 2017 Apr 05; 27():24-27. PubMed ID: 28325357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.